Key points are not available for this paper at this time.
OPEN ACCESS Patented Medicines Expenditure in Canada 1990–2022 8TH Edition ATTRIBUTION This legacy paper is corporately authored and edited based on proprietary template models and methods that are intended to facilitate regular updates. The design and content are
Brett Skinner (Wed,) studied this question.